BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10680053)

  • 21. Oxidatively modified LDL and atherosclerosis: an evolving plausible scenario.
    Jialal I; Fuller CJ
    Crit Rev Food Sci Nutr; 1996 Apr; 36(4):341-55. PubMed ID: 8740438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free radicals and antioxidants in cardiovascular disease.
    Maxwell SR; Lip GY
    Br J Clin Pharmacol; 1997 Oct; 44(4):307-17. PubMed ID: 9354304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits.
    Shaish A; Daugherty A; O'Sullivan F; Schonfeld G; Heinecke JW
    J Clin Invest; 1995 Oct; 96(4):2075-82. PubMed ID: 7560102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin E and atherosclerosis: beyond prevention of LDL oxidation.
    Meydani M
    J Nutr; 2001 Feb; 131(2):366S-8S. PubMed ID: 11160562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective.
    Jialal I; Devaraj S
    Clin Chem; 1996 Apr; 42(4):498-506. PubMed ID: 8605665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of atherosclerosis with the help of antioxidants].
    Jendryczko A
    Pol Tyg Lek; 1994 May 16-30; 49(20-22):456-8. PubMed ID: 7651913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis.
    Heinecke JW
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1261-4. PubMed ID: 11498450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanisms of anti-atherogenic action of probucol].
    Ohya T; Egusa G
    Nihon Rinsho; 1999 Dec; 57(12):2831-6. PubMed ID: 10638221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS).
    Hodis HN; Mack WJ; LaBree L; Mahrer PR; Sevanian A; Liu CR; Liu CH; Hwang J; Selzer RH; Azen SP;
    Circulation; 2002 Sep; 106(12):1453-9. PubMed ID: 12234947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The significance of ixidized low density lipoprotein in atherosclerosis].
    Hansen PR
    Ugeskr Laeger; 1996 May; 158(19):2706-10. PubMed ID: 8744072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential role of antioxidants in the prevention of atherosclerosis.
    Illingworth DR
    J Nutr Sci Vitaminol (Tokyo); 1993; 39 Suppl():S43-7. PubMed ID: 8164066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of oxidized lipoproteins in atherogenesis.
    Berliner JA; Heinecke JW
    Free Radic Biol Med; 1996; 20(5):707-27. PubMed ID: 8721615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis.
    Aviram M; Fuhrman B
    Atherosclerosis; 1998 Apr; 137 Suppl():S45-50. PubMed ID: 9694541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New pharmaceuticals for patients with atherosclerosis are under development. Antioxidants inhibit LDL modification].
    Björkhem I; Berglund L
    Lakartidningen; 1989 Sep; 86(39):3249-50, 3255. PubMed ID: 2796509
    [No Abstract]   [Full Text] [Related]  

  • 35. Probucol as an antioxidant and antiatherogenic drug.
    Kuzuya M; Kuzuya F
    Free Radic Biol Med; 1993 Jan; 14(1):67-77. PubMed ID: 8454225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of antioxidants to prevent atherosclerosis development and its clinical manifestations.
    Pettersson KS; Ostlund-Lindqvist AM; Westerlund C
    EXS; 1996; 76():21-31. PubMed ID: 8805786
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antioxidant vitamins--significance for preventing cardiovascular diseases. Part 1. Oxidized low-density lipoproteins and atherosclerosis; antioxidant dietary supplementation--vitamin E].
    Andreeva-Gateva P
    Vutr Boles; 2000; 32(3):11-8. PubMed ID: 11688317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical results with AGI-1067: a novel antioxidant vascular protectant.
    Tardif JC
    Am J Cardiol; 2003 Feb; 91(3A):41A-49A. PubMed ID: 12645643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The oxidative hypothesis of atherosclerosis and the use of antioxidants in coronary disease].
    Batlouni M
    Arq Bras Cardiol; 1997 Jan; 68(1):55-63. PubMed ID: 9334462
    [No Abstract]   [Full Text] [Related]  

  • 40. Antioxidants, cholesterol, and ischaemic heart disease: CHAOS or confusion?
    Winder AF
    J Clin Pathol; 1997 Apr; 50(4):269-70. PubMed ID: 9215138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.